mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia [0.03%]
Agnieszka Dąbkowska,Martyna Janowska,Agata Pastorczak et al.
Agnieszka Dąbkowska et al.
B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is characterized by impaired B-cell maturation and poor prognosis in relapsed/refractory (R/R) cases. While CD20-targeted immunotherapies offer clinical benefit, their efficacy is limi...
Jan-Niklas Eckardt,Martin Bornhäuser,Jan Moritz Middeke
Jan-Niklas Eckardt
A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia [0.03%]
Anne Marie Staehle,Florian Perner,Hans Felix Staehle et al.
Anne Marie Staehle et al.
Elevated activity of transcription factor NFE2 is sufficient to cause leukemic transformation in absence of a classical leukemic driver. However, the molecular mechanism promoting NFE2-driven leukemogenesis is not known. Here we report a pr...
Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS [0.03%]
Sonja Zweegman,Saad Z Usmani,Vania Hungria et al.
Sonja Zweegman et al.
Modeling KRAS mutations in KMT2A::MLLT3 acute myeloid leukemia promotes leukemic progression and transcriptional rewiring [0.03%]
Nayeli Esparza,Joan Defrêne,Eva Bresson et al.
Nayeli Esparza et al.
Karin Lind,Sayantanee Dutta,Marco Raffaele Cosenza et al.
Karin Lind et al.
Charles Hertz,Nikolaos Spyrou,Ronald Hoffman et al.
Charles Hertz et al.
Calreticulin (CALR) frameshift mutations drive the majority of JAK2/MPL-wild-type cases of essential thrombocythemia and myelofibrosis, producing a shared novel C-terminus that activates the thrombopoietin receptor and leads to constitutive...
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study [0.03%]
CASSIOPEIA研究中SLIM患者的预后分析
Cyrille Touzeau,Aurore Perrot,Cyrille Hulin et al.
Cyrille Touzeau et al.
Clonal hematopoiesis related to ionizing radiation in atomic bomb survivors [0.03%]
核爆幸存者放射线相关的克隆性血液生成
Masataka Taguchi,Shinya Sato,Yasuhito Nannya et al.
Masataka Taguchi et al.
Correction: CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia [0.03%]
纠正：CD7 CAR-T细胞治疗复发或难治性CD7阳性急性髓系白血病患者的疗效
Mingming Zhang,Lianxuan Liu,Shan Fu et al.
Mingming Zhang et al.
Published Erratum
Leukemia. 2026 Aug 10. DOI:10.1038/s41375-026-03091-1 2026